These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 31943410)

  • 21. Clustering and internalization of integrin alphavbeta3 with a tetrameric RGD-synthetic peptide.
    Sancey L; Lucie S; Garanger E; Elisabeth G; Foillard S; Stéphanie F; Schoehn G; Guy S; Hurbin A; Amandine H; Albiges-Rizo C; Corinne AR; Boturyn D; Didier B; Souchier C; Catherine S; Grichine A; Alexeï G; Dumy P; Pascal D; Coll JL; Jean-Luc C
    Mol Ther; 2009 May; 17(5):837-43. PubMed ID: 19259068
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of RGD-targeted albumin carriers for specific delivery of auristatin E to tumor blood vessels.
    Temming K; Meyer DL; Zabinski R; Dijkers EC; Poelstra K; Molema G; Kok RJ
    Bioconjug Chem; 2006; 17(6):1385-94. PubMed ID: 17105215
    [TBL] [Abstract][Full Text] [Related]  

  • 23. αVβ3 Integrin-Targeted Radionuclide Therapy with 64Cu-cyclam-RAFT-c(-RGDfK-)4.
    Jin ZH; Furukawa T; Degardin M; Sugyo A; Tsuji AB; Yamasaki T; Kawamura K; Fujibayashi Y; Zhang MR; Boturyn D; Dumy P; Saga T
    Mol Cancer Ther; 2016 Sep; 15(9):2076-85. PubMed ID: 27422811
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and biological evaluation of RGD and isoDGR peptidomimetic-α-amanitin conjugates for tumor-targeting.
    Bodero L; López Rivas P; Korsak B; Hechler T; Pahl A; Müller C; Arosio D; Pignataro L; Gennari C; Piarulli U
    Beilstein J Org Chem; 2018; 14():407-415. PubMed ID: 29520305
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis, biological studies and molecular dynamics of new anticancer RGD-based peptide conjugates for targeted drug delivery.
    Gilad Y; Noy E; Senderowitz H; Albeck A; Firer MA; Gellerman G
    Bioorg Med Chem; 2016 Jan; 24(2):294-303. PubMed ID: 26719208
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Shifting Towards α
    Bugatti K; Bruno A; Arosio D; Sartori A; Curti C; Augustijn L; Zanardi F; Battistini L
    Chemistry; 2020 Oct; 26(59):13468-13475. PubMed ID: 32634263
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interest of RGD-containing linear or cyclic peptide targeted tetraphenylchlorin as novel photosensitizers for selective photodynamic activity.
    Frochot C; Di Stasio B; Vanderesse R; Belgy MJ; Dodeller M; Guillemin F; Viriot ML; Barberi-Heyob M
    Bioorg Chem; 2007 Jun; 35(3):205-20. PubMed ID: 17223161
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Total synthesis and antitubulin activity of c10 analogues of cryptophycin-24.
    Buck SB; Huff JK; Himes RH; Georg GI
    J Med Chem; 2004 Jan; 47(3):696-702. PubMed ID: 14736249
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of
    Kaeopookum P; Petrik M; Summer D; Klinger M; Zhai C; Rangger C; Haubner R; Haas H; Hajduch M; Decristoforo C
    Nucl Med Biol; 2019; 78-79():1-10. PubMed ID: 31678781
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cyclic RGD-Functionalized
    Kawai K; Nishimura K; Okada S; Sato S; Suzuki M; Takata T; Nakamura H
    Mol Pharm; 2020 Oct; 17(10):3740-3747. PubMed ID: 32845640
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neutrophil Elastase Promotes Linker Cleavage and Paclitaxel Release from an Integrin-Targeted Conjugate.
    Raposo Moreira Dias A; Pina A; Dean A; Lerchen HG; Caruso M; Gasparri F; Fraietta I; Troiani S; Arosio D; Belvisi L; Pignataro L; Dal Corso A; Gennari C
    Chemistry; 2019 Feb; 25(7):1696-1700. PubMed ID: 30452790
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cryptophycin affinity labels: synthesis and biological activity of a benzophenone analogue of cryptophycin-24.
    Vidya R; Eggen M; Georg GI; Himes RH
    Bioorg Med Chem Lett; 2003 Feb; 13(4):757-60. PubMed ID: 12639575
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Toward the development of a novel non-RGD cyclic peptide drug conjugate for treatment of human metastatic melanoma.
    Redko B; Tuchinsky H; Segal T; Tobi D; Luboshits G; Ashur-Fabian O; Pinhasov A; Gerlitz G; Gellerman G
    Oncotarget; 2017 Jan; 8(1):757-768. PubMed ID: 27768593
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Total synthesis and anti-tubulin activity of epi-c3 analogues of cryptophycin-24.
    Buck SB; Huff JK; Himes RH; Georg GI
    J Med Chem; 2004 Jul; 47(14):3697-9. PubMed ID: 15214797
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cryptophycins-309, 249 and other cryptophycin analogs: preclinical efficacy studies with mouse and human tumors.
    Liang J; Moore RE; Moher ED; Munroe JE; Al-awar RS; Hay DA; Varie DL; Zhang TY; Aikins JA; Martinelli MJ; Shih C; Ray JE; Gibson LL; Vasudevan V; Polin L; White K; Kushner J; Simpson C; Pugh S; Corbett TH
    Invest New Drugs; 2005 Jun; 23(3):213-24. PubMed ID: 15868377
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [(68)Ga]FSC-(RGD)3 a trimeric RGD peptide for imaging αvβ3 integrin expression based on a novel siderophore derived chelating scaffold-synthesis and evaluation.
    Knetsch PA; Zhai C; Rangger C; Blatzer M; Haas H; Kaeopookum P; Haubner R; Decristoforo C
    Nucl Med Biol; 2015 Feb; 42(2):115-22. PubMed ID: 25459110
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Conjugates of modified cryptophycins and RGD-peptides enter target cells by endocytosis.
    Nahrwold M; Weiß C; Bogner T; Mertink F; Conradi J; Sammet B; Palmisano R; Royo Gracia S; Preuße T; Sewald N
    J Med Chem; 2013 Mar; 56(5):1853-64. PubMed ID: 23387527
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 67Cu-Radiolabeling of a multimeric RGD peptide for αVβ3 integrin-targeted radionuclide therapy: stability, therapeutic efficacy, and safety studies in mice.
    Jin ZH; Furukawa T; Ohya T; Degardin M; Sugyo A; Tsuji AB; Fujibayashi Y; Zhang MR; Higashi T; Boturyn D; Dumy P; Saga T
    Nucl Med Commun; 2017 Apr; 38(4):347-355. PubMed ID: 28291159
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.